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Abstract
Obesity is an inflammatory state characterized by an augment in circulating inflammatory factors. Leptin may modulate the
synthesis of these factors by white adipose tissue decreasing insulin sensitivity. We have examined the effect of chronic
central administration of leptin on circulating levels of cytokines and the possible relationship with cytokine expression and
protein content as well as with leptin and insulin signaling in subcutaneous and visceral adipose tissues. In addition, we
analyzed the possible correlation between circulating levels of cytokines and peripheral insulin resistance. We studied 18
male Wistar rats divided into controls (C), those treated icv for 14 days with a daily dose of 12 mg of leptin (L) and a pair-fed
group (PF) that received the same food amount consumed by the leptin group. Serum leptin and insulin were measured by
ELISA, mRNA levels of interferon-c (IFN-c), interleukin-2 (IL-2), IL-4, IL-6, IL-10 and tumor necrosis factor-a (TNF-a) by real
time PCR and serum and adipose tissue levels of these cytokines by multiplexed bead immunoassay. Serum leptin, IL-2, IL-4,
IFN-c and HOMA-IR were increased in L and TNF-a was decreased in PF and L. Serum leptin and IL-2 levels correlate
positively with HOMA-IR index and negatively with serum glucose levels during an ip insulin tolerance test. In L, an increase
in mRNA levels of IL-2 was found in both adipose depots and IFN-c only in visceral tissue. Activation of leptin signaling was
increased and insulin signaling decreased in subcutaneous fat of L. In conclusion, leptin mediates the production of
inflammatory cytokines by adipose tissue independent of its effects on food intake, decreasing insulin sensitivity.
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Introduction
Obesity is associated with an inflammatory state involved in the
pathogenesis of many obesity related comorbidities. Previous
findings indicate that inflammatory diseases mediate energy and
weight deregulation though different proinflammatory cytokines
[1,2], whose levels are increased in both the circulation and
peripheral tissues [3]. These changes predispose an individual to
the development of type 2 diabetes mellitus, with this disease being
associated with total and visceral obesity [4,5].
Leptin modulates food intake, body weight and adipose stores,
with a direct correlation between serum leptin levels, gene
expression leptin in adipocytes and body fat [6]. Non-adipose
cells are considered to be responsible for the production of the
majority of proinflammatory factors [7], but adipocytes also
synthetizes several cytokines [8]. Leptin also regulates immune
function, playing a role in starvation-induced immunosuppression
[9]. Deficient leptin signaling impairs cellular responses, whereas
immune and malnutrition-related diseases are associated with
increased synthesis of leptin and of inflammatory cytokines. In
fact, leptin stimulates the production of proinflammatory cytokines
by monocytes, largely distributed in the adipose tissue [10].
Hyperleptinemia is associated with insulin resistance. Although
leptin initially increases insulin sensitivity, long-term exposure to
high leptin levels has been reported to result in insulin resistance
[11]. Leptin is a mediator of the inflammatory response that
impairs insulin signaling in the hypothalamus and adipocytes
[12,13]. This inflammatory state favours the release of macro-
phage chemoattractant proteins, triggering insulin resistance that
in turn induces a subsequent increase in circulating cytokines and
fatty acids, leading to a lipotoxic state in non-adipose tissues that
aggravates the pathological situation [14]. In addition, insulin
resistance increases inflammatory cytokine synthesis in adipocytes,
contributing to the exacerbation of this state [15].
The effect of exogenous leptin on insulin’s actions and
metabolic outputs has been studied mainly in leptin-deficient
patients, as well as in models of experimental diabetes or obesity
[11,16]. However, there is little information in normal animals
regarding the effect of leptin on the expression of proinflammatory
cytokines in adipose tissue. The fact that leptin decreases food
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intake must also be kept in mind since the amount of food
consumed may alter insulin sensitivity and the cytokine profile
[17,18], making it important to discriminate between the direct
effects of leptin from those due to decreased food intake.
In the present study, we investigated how chronic exposure to
increased leptin levels could modify the systemic cytokine profile
and insulin resistance in a non-obese model. To discriminate
between the direct effects of leptin and its induction of reduced
food intake, a group of pair-fed rats was analyzed. The potential
contribution of subcutaneous and visceral adipose tissues to the
modifications in the cytokine profile was also examined.
Results
General characteristics of experimental groups
Food intake and body weight were recorded to verify that icv
leptin infusion affected these parameters. On the fourth day of
treatment, food intake was reduced in L and PF with respect to C
(Fig. 1A); whereas the appearance of differences in body weight in
L was found on the eighth day with respect to the C and PF groups
(Fig. 1B). Epididymal fat mass was reduced in both PF and L, with
this reduction being greater in L (Fig. 1C). Serum leptin levels
were increased in L (Fig. 1D). Glycemia (Fig. 1E) and serum
insulin levels (Fig. 1F) showed no significant differences among the
experimental groups.
Chronic leptin administration changed serum
proinflammatory cytokine levels, increased HOMA-IR
index and attenuated the central and peripheral insulin
effects on glycemia
Serum levels of IL-2, IL-4 and IFN-c were increased in L with
respect to C and PF (Fig. 2A, B and E, respectively). Interleukin-6
and -10 levels showed no differences among the groups (Fig. 2C
and D, respectively), whereas TNF-a levels were reduced in PF
and L (Fig. 2F).
As inflammation is correlated with insulin resistance [19] we
first calculated the homeostasis model assessment of insulin
resistance (HOMA-IR). This insulin-related resistance index was
increased in L compared to C and PF (Fig. 3A). To examine if
HOMA-IR shows a relationship with serum cytokine values, linear
correlation regressions were performed. There was a positive
correlation of HOMA-IR with serum leptin, IL-2 and IL-4 levels
(Table 1).
As icv insulin administration increases glycemia [12,20], we also
evaluated insulin sensitivity by measuring changes in serum
glucose levels after central insulin infusion. Although blood
glucose levels were in the normal physiological range in all groups
throughout the study, previous chronic exposure to leptin reduced
the rise in glycemia induced by icv insulin injection (Fig. 3B).
Negative correlations of delta of glycemia with serum leptin, IL-2
and IL-4 levels were found (Table 1).
As central leptin may modify peripheral insulin response, we
also investigated whether chronic icv leptin infusion would be
accompanied by reduced insulin tolerance. Although we found no
differences in basal glycemia, a rapid drop of glycemia was
observed throughout the ip insulin tolerance test (IPITT) in
control and pair-fed rats, whereas only a modest reduction of
glucose levels was detected in leptin-treated rats (Fig. 3C). Linear
Figure 1. General characteristics of experimental animals. A.
Mean daily food intake in rats that received saline (C) or chronic leptin
(L) and the pair-fed group (PF). B. Mean body weight measurements
throughout the study in the same groups. C. Epididymal fat content in
the same groups. D. Serum leptin concentrations in the same groups.
E. Serum glucose concentrations in the same groups. F. Serum insulin
concentrations in the same groups. NS, non-significant; *p,0.05,
**p,0.01, ***p,0.01 by ANOVA. * in panels A and B indicates
significant difference (p,0.05) between C and L or PF groups, whereas
# indicates significant difference (p,0.05) between PF and L groups.
doi:10.1371/journal.pone.0046893.g001
Figure 2. Serum levels of cytokines. A. Serum interleukin (IL)-2
levels in rats that received saline (C) or chronic leptin (L) and the pair-
fed group (PF). B. Serum IL-4 levels in the same groups. C. Serum IL-6
levels in the same groups. D. Serum IL-10 levels in the same groups. E.
Serum interferon c (IFN-c) levels in the same groups. F. Serum tumor
necrosis a (TNF-a) levels in the same groups. NS, non-significant;
*p,0.05, **p,0.01, ***p,0.001 by ANOVA.
doi:10.1371/journal.pone.0046893.g002
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regression analyses showed that HOMA-IR presented a direct
correlation with serum cytokine levels, whereas the correlation
between the D in glycemia and cytokine levels was negative.
Finally, the relationship of the area under the curve for glucose
(AUC) after the IPITT was negative with leptin and IL-2 whereas
no significant correlation with was observed with IL-4 levels
(Table 1).
Effect of leptin on relative mRNA and protein levels of
cytokines in subcutaneous and visceral adipose tissues
To determine whether adipose tissue contributes to the
generation of the systemic inflammatory profile found in leptin-
treated rats, we studied relative messenger RNA levels of IL-2, IL-
4, IFN-c TNF-a in subcutaneous and visceral adipose tissues. IL-2
mRNA levels were increased in subcutaneous and visceral tissues
of L (Fig. 4A and 5A, respectively), whereas mRNA levels of IFN-c
only increase in visceral adipose tissue (Fig. 5C). No changes in the
mRNA levels of TNF-a were seen in either tissue (Fig. 4E and 5E).
Messenger RNA levels of IL-4 were very low and could not be
adequately quantified.
Circulating cytokine levels are the result of the synthesis and
liberation by several tissues. We analyzed protein concentrations
of IL-2, IL-4, IFN-c TNF-a in subcutaneous and visceral adipose
tissue. IL-2 protein levels in subcutaneous adipose tissue were not
different between the three groups (Fig. 4B), but was decreased in
Figure 3. Homeostasis model assessment of insulin resistance
(HOMA-IR), insulin sensitivity as delta (D) in glycemia after
intracerebroventricular insulin infusion (ICVII) and glycemia
during an intraperitoneal insulin tolerance test (IPITT). A.
HOMA-IR index in rats that received saline (C) or chronic leptin (L) and
pair-fed group (PF). B. Delta (D) in glycemia ([glycemia after 120 min of
insulin bolus] – [glycemia before insulin bolus]) in rats that received
saline plus acute insulin (insulin, C+I), chronic leptin plus acute insulin
(L+I) and the pair-fed group plus insulin (PF+I). C. Serum glucose levels
before (0 min) and during (30, 60, 90 and 120 min) an IPITT. *p,0.05,
**p,0.01 by ANOVA.
doi:10.1371/journal.pone.0046893.g003
Table 1. Linear correlations of homeostasis model
assessment of insulin resistance (HOMA-IR), D glycemia
([glycemia after 120 min of insulin bolus] – [glycemia before
insulin bolus]) after intracerebroventricular insulin infusion
(ICVII) and area under the curve (AUC) after intraperitoneal
insulin tolerance test (IPITT) with serum levels of leptin,
interleukin (IL)-2 and IL-4.
Leptin IL-2 IL-4
HOMA-IR
HOMA index r = 0.64** r = 0.66** r = 0.67**
ICVII
D glycemia r =20.66** r =20.64** r =20.57*
IPITT
AUC r =20.58** r =20.56* r =20.39 (NS)
r, correlation coefficient; NS, non-significant; *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0046893.t001
Figure 4. Relative mRNA and protein content of cytokines in
subcutaneous adipose tissue. A. Relative mRNA levels of interleu-
kin-2 (IL-2) in inguinal fat of rats that received saline (C) or chronic leptin
(L) and pair-fed group (PF). B. Protein content of IL-2 in the same
groups. C. Relative mRNA levels of interferon-c (IFN-c) in the same
groups. D. Protein content of IFN-c in the same groups. E. Relative
mRNA levels of tumor necrosis factor a (TNF-a) in the same groups. F.
Protein content of TNF-a in the same groups. NS, non-significant;
*p,0.05 by ANOVA.
doi:10.1371/journal.pone.0046893.g004
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L with respect to C and PF in visceral adipose tissue (Fig. 5B). In L
protein levels of IFN-c were increased in both adipose depots
(Fig. 4D and 5D) and TNF-a decreased in visceral adipose tissue
(Fig. 5F), with no change in subcutaneous fat (Fig. 4F, Table 1).
Finally, protein concentrations of IL-4 were increased in the
subcutaneous adipose tissue of L with respect to C and PF groups
(6.1260.87, 5.7661.09 and 8.9460.61, expressed in pg of IL-4/
mg of protein in C, PF and L groups, respectively), whereas no
changes in visceral adipose tissue were seen (11.4462.37,
10.4461.06 and 10.5460.92, expressed in pg of IL-4/mg of
protein in C, PF and L groups, respectively).
Immune and inflammatory markers in the different
adipose compartments
As specific cell infiltration could affect the reported inflamma-
tory profile, we have analyzed several markers, expressed in
different cell types. The levels of F4/80 are undetectable in
subcutaneous and visceral adipose tissue of controls; however, a
strong signal was detected in both fat depots of L group. Vimentin
was increased in subcutaneous compartment of L (Fig. 6A) and
decreased in visceral adipose tissue of L group (6B). Finally, levels
of haptoglobin were increased in subcutaneous (Fig. 6C) and
visceral adipose tissue (Fig. 6D), showing a direct correlation with
IL-2 in both localizations (Fig. 6E and 6F).
Intracellular signaling pathways of leptin and insulin in
adipose tissue after leptin and insulin infusion
Leptin mRNA levels were increased in subcutaneous fat of L
(Fig. 7A), with no change in visceral fat (Fig. 7B). The mRNA
levels of ObRb were increased in subcutaneous adipose of L
(Fig. 7C) and in visceral fat of PF (Fig. 7D). Phosphorylation of
signal transducer and activator of transcription 3 (STAT3) at
Ser727 was increased in the subcutaneous adipose tissue of L
(Fig. 7E), whereas in visceral tissue it was increased in both PF and
L, with this increase being greater in PF (Fig. 7F). Levels of
suppressor of cytokine signaling 3 (SOCS3) were unchanged in
subcutaneous and visceral fat (Fig. 7G and 7H, respectively and
Table 2).
To determine if chronic exposure to increased leptin levels
modulates insulin signaling, we examined insulin receptor b chain
(IRb) levels in subcutaneous and visceral tissues. Levels of IRb in
subcutaneous fat were not different between the experimental
groups (Fig. 8A) and were reduced in visceral fat of L with respect
to C and PF (Fig. 8B). Phosphorylation of Akt at Ser 473 was
reduced in subcutaneous and visceral adipose of PF and L (Fig. 8C
and 8D, respectively). No differences were detected in phosphor-
ylation of this target between PF and L in subcutaneous tissue
(Fig. 8C), whereas in visceral adipose tissue, the levels of Akt
phosphorylation were lower in L compared to PF (Fig. 8D).
We have determined Akt activation after insulin infusion in both
fat pads. Phosphorylation of Akt at Ser 473 was reduced in
subcutaneous adipose tissue of leptin-treated rats (100.067.9 vs.
44.864.1, p,0.01; in C plus insulin and L plus insulin,
respectively), whereas no differences were detected in visceral fat
(100.0620.2 vs. 119.3614.7, p = 0.79; in C plus insulin and L plus
insulin, respectively) after central insulin infusion. We also
analyzed Akt activation after IPIIT in both compartments.
Phosphorylation of Akt at Ser 473 was decreased in subcutaneous
adipose tissue (100.069.7 vs. 57.066.5, p,0.05; in C plus insulin
and L plus insulin, respectively) as in visceral fat (100.0611.2 vs.
Figure 5. Relative mRNA and protein content of cytokines in
visceral adipose tissue. A. Relative mRNA levels of interleukin-2 (IL-
2) in epididymal fat of rats that received saline (C) or chronic leptin (L)
and the pair-fed group (PF). B. Protein content of IL-2 in the same
groups. C. Relative mRNA levels of interferon-c (IFN-c) in the same
groups. D. Protein content of IFN-c in the same groups. E. Relative
mRNA levels of tumor necrosis factor a (TNF-a) in the same groups. F.
Protein content of TNF-a in the same groups. NS, non-significant;
*p,0.05, ***p,0.001 by ANOVA.
doi:10.1371/journal.pone.0046893.g005
Figure 6. Immune and inflammatory markers in adipose
compartments. A. Relative vimentin protein levels in inguinal fat of
rats that received saline (C) or chronic leptin (L) and the pair-fed group
(PF). B. Relative vimentin protein levels in epididymal fat of the same
groups. C. Haptoglobin levels in inguinal fat of the same groups. D.
Haptoglobin levels in epididymal fat of the same groups. E. Linear
regression analysis between interleukin-2 (IL-2) and haptoglobin in
inguinal fat. F. Linear regression analysis between interleukin-2 (IL-2)
and haptoglobin in epididymal fat. Correlation coefficients (r) and p
values are represented for each analysis. DU, densitometry units;
*p,0.05 by ANOVA, ***p,0.001 by ANOVA.
doi:10.1371/journal.pone.0046893.g006
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75.663.4, p,0.05; in C plus insulin and L plus insulin,
respectively).
Levels of forkhead box-containing protein O-1 (FOXO1) were
increased in subcutaneous fat of L and visceral fat of PF and L
(Fig. 8E and 8F, respectively, Table 2). Protein tyrosine
phosphatase 1B (PTP1B) was increased in L respect to C and
PF in subcutaneous adipose tissue (8G) and diminished in visceral
depot of L group (8H).
Discussion
This study demonstrates that chronic central leptin administra-
tion causes a serum inflammatory profile correlated to insulin
resistance. Adipose tissue contributes to the rise in circulating
cytokine levels in leptin-treated rats and this increase does not
seem to be correlated to the lower insulin sensitivity in adipose
tissue. A direct effect of increased leptin levels exists as serum levels
of most cytokines did not differ between pair-fed rats and controls.
Figure 7. Leptin signaling in subcutaneous and visceral fat. A. Relative mRNA levels of leptin in inguinal fat of rats that received saline (C) or
chronic leptin (L) and the pair-fed group (PF). B. Relative mRNA levels of leptin in epididymal fat of the same groups. C. Relative mRNA levels of the
long form of the leptin receptor (ObRb) in inguinal fat of the same groups. D. Relative mRNA levels of ObRb in epididymal fat of the same groups. E.
Relative phosphorylated (p) signal transducer and activator of transcription factor 3 phosphorylated on serine 727 (pSer727-STAT3) protein levels in
inguinal fat of the same groups. F. Relative pSer727-STAT3 protein levels in epididymal fat of the same groups. G. Relative suppressor of cytokine
signaling 3 (SOCS3) protein levels in inguinal fat of the same groups. H. Relative SOCS3 protein levels in epididymal fat of the same groups. The data
are expressed as a percentage of the control ratio. DU, densitometry units; NS, non-significant; *p,0.05 by ANOVA **p,0.01 by ANOVA.
doi:10.1371/journal.pone.0046893.g007
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Leptin induced a proinflammatory profile in serum, as
previously shown [21], consistent with an elevation of inflamma-
tory cytokines and leptin in obese patients [22]. There is increasing
evidence that leptin enhances proinflammatory immune responses
in different blood cell types, some of which are infiltrated in
adipose tissue [23]. In addition, correlations between serum levels
of leptin and several interleukins, as well as with IFN-c, have been
shown in several pathologies associated with inflammation
[24,25,26]. In spite of an increase in several proinflammatory
cytokines, serum TNF-a levels were reduced after leptin infusion.
However, this decline is most likely not a direct effect of leptin, as
similar TNF-a level were found in pair-fed rats. In fact, reduced
food intake may have some anti-inflammatory effects and a low
caloric diet not only ameliorates serum proinflammatory profiles,
but also decreases the mRNA expression of up-regulated
chemokines in obese patients [27].
Our experimental model reproduces a low-grade peripheral
inflammatory situation without obesity, but where hyperleptine-
mia is present. We and others have reported that this experimental
model of leptin infusion induces weight loss, central changes in
leptin and insulin signaling and hyperleptinemia [12,28]. Although
we cannot discard the contribution of exogenous leptin to the rise
Table 2. Serum cytokine levels (pg/ml), insulin resistance or sensitivity indexes, relative mRNA levels and concentration of
cytokines in subcutaneous and visceral adipose tissue (pg/mg of protein) and intracellular signaling (expressed as % control) in
both fat depots.
Control Pair-fed Leptin
Serum Cytokines Leptin 3.0460.63 2.0260.52 13.7562.86 *** ###
IL-2 75.5622.1 70.669.8 185.7623.6 ** ##
IL-4 3.3961.16 2.8160.88 12.0762.00 *** ###
IFN-c 24.466.8 28.4610.3 * 44.8612.8 * #
TNF-a 2.6160.37 0.9560.32 *** 0.6760.22 ***
Insulin-
indexes
HOMA-IR 3.9860.45 3.7060.52 7.7261.76 * #
D glycemia 42.965.4 40.763.8 18.564.0 ** ##
Subcutaneous/
visceral
Relative
mRNA levels
IL-2 100634/
100632
143655/
161648
239666 */
303656 *
IFN-c 100629/
100631
131646/
2236112
159637/
11266648 *** ###
TNF-a 100642/
100625
67621/
216680
98619/
208654
Protein levels IL-2 76.064.7/
92.569.6
73.865.5/
102.867.0
86.3610.8/
68.565.9 * #
IFN-c 0.8260.20/
1.8460.34
1.1460.22/
2.6060.52
2.7660.62 * #/
5.5861.05 * #
TNF-a 0.1560.03/
2.2960.15
0.1460.02/
1.9660.14
0.1660.06/
0.7160.24 * #
Immune –
inflammatory
markers
Vimentin 100615/
100613
124613/
119626
144615 */
561 *** ###
Haptoglobin 1.0160.59/
2.8361.53
1.5660.26/
5.4662.27
7.1660.69 ** ##/
10.6061.54 *
Intracellular signaling ObRb 100618/
100639
198669/
439649 **
620692 ** ##/ 163652 ##
p/t STAT3 100622/
100633
258623/
5086139 **
744657 ** ##/
242676 ** ##
SOCS3 100613/
100619
6669
79624
8869/
72616
IR 100613/
100611
121610/
95618
13069/
59622 * #
p/t Akt 100612/
10061
47621 */
5867 *
42619 */
2764 * #
FOXO1 100624/
100617
136633/
127613
207640 */
182636 * #
PTP1B 100625/
10069
109628/
109621
187611 * #/
1468 *** ###
FOXO1, forkhead box O number 1; HOMA-IR, homeostasis model assessment of insulin resistance; IL, interleukin; IFN-c, interferon-c; IR, insulin receptor; ObRb, long form
of leptin receptor; p/t, phosphorylated/total; PTP1B, protein tyrosine phosphatase 1B; SOCS3, suppressor of cytokine signaling 3; STAT3, transducer and activator of
transcription factor 3; TNF-a, tumor necrosis factor a. *p,0.05, **p,0.01, ***p,0.001 by ANOVA vs. control; #p,0.05, ##p,0.01, ###p,0.001 by ANOVA vs. pair-fed
group.
doi:10.1371/journal.pone.0046893.t002
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in serum levels, leptin synthesis in subcutaneous adipose tissue is
augmented and this may contribute to the increase in circulating
levels. The mechanism by which an increase in central leptin levels
stimulates leptin expression in fat depots is not well known, but it
has been reported that central leptin infusion stimulates triiodo-
thyronine production [29,30]. This thyroid hormone increases the
expression of leptin mRNA in subcutaneous fat depots [31] and
also in adipocytes in vitro [32]. Although the main role of leptin is
to regulation body weight by affecting food intake [33], it has
additional effects on carbohydrate and lipid metabolism [34] that
could explain the differences in weight gain between pair-fed and
leptin-treated rats. Additionally, weight loss could also be
potentiated by the levels of systemic cytokines [35].
Previous studies have demonstrated the relationship between
obesity, hyperleptinemia and reduced insulin sensitivity and the
beneficial effect of weight loss on insulin action [36,37]. Our
model produces a low-grade peripheral inflammation without
obesity where hyperleptinemia is present and there is a correlation
between leptin and several interleukins with peripheral insulin
resistance. This interesting finding has been previously reported in
patients where plasma leptin levels correlate with HOMA-IR
independently of the effect of obesity [38], indicating a key role of
hyperleptinemia per se in the generation of this adverse profile and
suggesting that the contribution of adipose tissue may be more
closely related to its functional state, than to its total amount. In
addition, a direct effect of leptin has been shown in clinical studies
where induced hyperleptinemia contributes to increase insulin
Figure 8. Insulin signaling in subcutaneous and visceral fat. A. Relative levels of the insulin receptor beta chain (IRb) in inguinal fat of rats that
received saline (C) or chronic leptin (L) and the pair-fed group (PF). B. Relative IRb levels in epididymal fat of the same groups. C. Relative
phosphorylated (p) Akt on serine 473 (pSer473-Akt) protein levels in inguinal fat of the same groups. D. Relative pSer473-Akt protein levels in
epididymal fat of the same groups. E. Relative levels of the forkhead box-containing protein O-1 (FOXO1) in inguinal fat of the same groups. F.
Relative FOXO1 levels in epididymal fat of the same groups. G. Relative levels of the protein tyrosine phosphatase 1B (PTP1B) in inguinal fat of the
same groups. H. Relative PTP1B levels in epididymal fat of the same groups. The data are expressed as a percentage of the control ratio. DU,
densitometry units; NS, non-significant; *p,0.05 by ANOVA, ***p,0.001 by ANOVA.
doi:10.1371/journal.pone.0046893.g008
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resistance, whereas interruption of treatment ameliorates the
sensitivity to insulin [11]. We have assessed insulin sensitivity after
insulin challenge by using a central insulin bolus, because this
infusion increased glycemia [12,39]. The attenuated response in L
suggest that chronic exposure to icv leptin decreased central insulin
control of glucose levels [20], although we cannot exclude an effect
of leptin treatment on peripheral tissues. Finally, we also evaluated
insulin sensitivity after a classical intraperitoneal insulin tolerance
test, observing a lower decrease in serum glucose levels in leptin-
treated rats, thus suggesting reduced insulin sensitivity. Taken
together, these results seem to indicate that leptin modify the
response to insulin administration by decreasing its sensitivity.
Two of the main targets of leptin are STAT3 and SOCS3. In
adipose tissue activation of STAT3 was coincident with increased
expression of the leptin receptor. Although the direct action of
leptin on the expression of its receptor is controversial, a positive
effect has been previously reported [40], as we described here in
inguinal adipose tissue. In contrast to subcutaneous adipose, in
epididymal fat leptin receptor mRNA levels were increased in
pair-fed rats. The positive effect of caloric restriction on leptin
receptors has been reported [41], suggesting that moderate food
reduction improves leptin signaling in some localizations. Hence,
depot-specific differences have been reported both in experimental
animals [42] and lean and obese patients [43].
Leptin modulates the production of interleukins in different cell
types, including T cells and macrophages [44,45] and generates an
inflamed state in adipose tissue, probably regulated by crosstalk
between adipocytes and macrophages [46,47]. As mentioned
above, the main findings reported here are the increase in mRNA
levels of IL-2 in both inguinal and epididymal fat pads, the marked
augment in IFN-c mRNA in epididymal fat, and particularly, the
increased pSTAT3 levels without changes in SOCS3 in sub-
cutanteous fat in response to chronic leptin administration. The
lack of leptin-induced STAT3 signaling is associated with reduced
cytokine production [48], whereas leptin exposure increases both
STAT3 activation and chemokine expression in macrophages
[10]. Thus, the activation of leptin signaling reported here may
account for the rise in the mRNA levels of cytokines. Not all
changes in mRNA levels were related with changes in protein
levels in adipose tissue, which is most likely due to increased
secretion that would contribute to the generation of the serum
inflammatory profile. However, the relationship is direct for some
cytokines, such as IFNc in visceral adipose. In contrast, TNF-a
gene expression and levels in adipose tissue do not show an
apparent relationship with serum profile. We must keep in mind
that reduced food intake reduces white adipose tissue and leptin
selectively decreases visceral adiposity [49], as we report here.
Thus, although there are no changes in TNF-a mRNA levels per
gram of adipose tissue, a decrease in the total amount of adipose
tissue could contribute to the reduction of serum TNF-a.
Obesity and hyperleptinemia are associated with a proinflam-
matory state, with infiltration of different cell types, such as
macrophages into adipose tissue [7]. The presence of the
macrophage marker F4/80 after chronic leptin infusion indicates
the presence of these cells in both fat depots that could participate
in several inflammatory pathways [50]. Moreover, an interaction
between macrophages and adipocytes has been reported [51],
affecting insulin resistance mediated by the reduction of Akt
phosphorylation, as we show here. Mesenchymal stromal cells,
present in adipose tissue, are involved in anti-inflammatory
processes, modulating the secretion of several interleukins [52].
We have found a reduction of vimentin, a mesenchymal marker
[53,54] in visceral fat depot, which could exacerbate inflammation
and partial insulin resistance observed after chronic leptin
treatment. In this regard, transplantation of adipose-derived
mesenchymal cells increased phosphorylation of Akt [55], whereas
macrophages inhibit differentiation of these cells. Hence, infiltra-
tion of macrophages in patients with obesity restrains this
physiological process via secretion of proinflammatory cytokines
[56]. Adipocytes also participate in the inflammatory state,
expressing cytokines and their receptors [8]. Haptoglobin, a
marker of inflammation is mainly synthetized by hepatocytes and
adipocytes and its synthesis is upregulated by cytokines [57]. This
adipose marker could exacerbate insulin resistance as it has been
reported than impairment of glucose homeostasis is diminished by
haptoglobin deficiency [58].
The data reported herein indicate that food restriction impairs
insulin signal transduction in subcutaneous and visceral fat pads
with leptin potentiating this effect in visceral tissue. Although
reduction of food intake may initially attenuate insulin resistance
[59], it has been stated that food restriction during the same length
of time could lead to a down-regulation of insulin signaling in
adipose tissue [60]. These authors demonstrate that this negative
effect was due to the reduction in phosphorylation of the insulin
receptor, together with a decrease of insulin receptor substrates,
which could explain the reduced Akt phosphorylation. It appears
that decreased insulin sensitivity in adipose tissue does not
contribute in a significant manner to the change in the
proinflammatory profile as pair-fed rats exhibit a cytokine profile
similar to controls, with the exception of the levels of TNF-a.
However, the pronounced reduction of Akt phosphorylation in
visceral fat in the L group could be related to a direct effect of
leptin and/or cytokines, as leptin directly decreases insulin-
dependent autophosphorylation in adipocytes [13] and inflamma-
tory cytokines may induce insulin resistance by decreasing insulin
receptor levels [61], as we found in visceral fat. Alternatively,
cytokine down-regulation of insulin receptor substrate expression
[62] could explain the profound reduction of Akt phosphorylation
reported here. Chronic leptin-treated rats present higher FOXO1
levels that could be the result of the lower Akt phosphorylation. In
fact, activation of Akt reduces this factor by promoting subsequent
polyubiquitylation and degradation by an ubiquitin proteasome
system [63]. Thus, higher hypothalamic levels of FOXO1 in L
group could be the result of a leptin-induced reduction in nuclear
export of FOXO1 and cytoplasmic degradation [64]. Protein
tyrosine phosphatase1B has been shown to be a negative regulator
of insulin action and we have found an increase of PTP1B beside a
reduction of insulin signaling in subcutaneous fat depot, as it has
previously reported [65]. Unexpectedly, we observed a great
reduction of levels of this protein in visceral fat. Nevertheless, it has
been recently shown that PTP1B deficiency can exacerbate
inflammatory processes [66], showing higher sensitivity to IFN-c
effects [67].
We cannot discard a negative effect of IFN-c on insulin
sensitivity in adipose tissue, as its administration induces sustained
loss of insulin-stimulated glucose uptake, coincident with reduced
Akt phosphorylation and STAT activation [61]. These authors
also observed that JAK inhibition restored glucose uptake and Akt
phosphorylation, in accordance with the results reported here
showing an inverse relationship between IFN-c levels and insulin
signaling. In a similar way, increased serum IL-2 levels, as well as
synthesis of IL-2 in epididymal fat, may contribute to reduce
insulin sensitivity in adipose tissue [8]. Thus, these results suggest
that leptin could affect insulin signaling in visceral tissue by
modulating the synthesis of cytokines.
Several caveats should be taken into consideration when
evaluating these results. Adipose tissue has different cell types
and this study does not quantify the contribution of adipocytes or
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other cells in the generation of an inflammatory response. We also
must take into account that we have reported a decrease in the
content of epididymal fat, but not in subcutaneous adipose tissue,
which was not been quantified. However, previous studies indicate
that food restriction and leptin administration at similar doses
decrease subcutaneous fat content by approximately 50% [68,69];
thus, the contribution of fat depots to circulating cytokine levels is
the resultant of the balance between cytokine synthesis and
amount of adipose tissue. We cannot differentiate between the
central effects of leptin from those due to increased circulating
levels, as changes in metabolism and gene expression in fat are
similar in most of the analyzed parameters by both administration
routes [32] and denervation of white adipose tissue is necessary to
make this distinction. In addition, synthesis of leptin in adipose
tissue also may contribute to increased serum levels. Central
infusion was chosen as it has more profound effects not only in
food restriction and body weight, but also on carbohydrate and
lipid metabolism [70,71]. Finally, although we did not detect
seizures or coma after i.p. insulin administration, the possible
appearance of these symptoms in fasted animals should be taken
into account. In addition, the fact that counterregulatory
mechanisms in fasted animals will be activated in an attempt to
avoid the hypoglycemia and this response could be different
between the experimental groups must be considered. To avoid
this marked decrease in serum glucose levels after the IPITT, a
lower dose of insulin [72] could possibly be used.
In conclusion, our findings indicate that chronic leptin
administration produces a serum inflammatory profile closely
correlated with lower insulin sensitivity. Adipose tissue contributes
to the generation of this adverse profile and the increased synthesis
of cytokines seems to be related with the activation of leptin
signaling and independent of insulin resistance in both fat depots.
These results suggest that pharmacological inhibition of leptin
signaling in adipose tissue could be of interest for reducing the low
grade inflammatory state associated to obesity.
Materials and Methods
Materials
All chemicals were purchased from Sigma-Aldrich, Inc. (St.
Louis, MO, USA) unless otherwise noted. The Inmmun-Star
Western C Kit (ECL) was from Bio-Rad Laboratories (Hercules,
CA, USA) and recombinant rat leptin was purchased from
Preprotech (Rocky Hill, NJ, USA). Antibodies for phosphorylated
(p)-Ser473-Akt, p-Ser727-signal transducer and activator of
transcription factor 3 (pSer727-STAT3) and suppressor of
cytokine signaling 3 (SOCS3) were from Cell Signaling Technol-
ogy (Danvers, MA, USA), antibodies against Akt, F4/80, FOXO1
and IRb were from Santa Cruz Biotechnology Inc. (Santa Cruz,
CA, USA), the antibody against STAT3 from R&D Systems
(Minneapolis, MN, USA) and the antibody to actin from Thermo
Fisher Scientific (Fremont, CA, USA). Antibody for PTP1B was
from Millipore Corporate Headquarters (Billerica, MA, USA) and
antibody against vimentin from Sigma-Aldrich. The correspond-
ing secondary antibodies conjugated with horseradish-peroxidase
were purchased from Thermo Fisher Scientific Inc. (Waltham,
MA, USA).
The rat leptin and insulin ELISA kits and multiplexed bead
immunoassay for IL-2, -4, -6 -10, IFN-c and TNF-a were from
Millipore Corporate Headquarters (Billerica, MA, USA). TaqMan
gene expression assays were purchased from Applied Biosystems
(Foster City, CA, USA).
Animals
This study was approved by the Ethics Committee of the
Universidad de Alcala´ de Henares (SAF 2010–22277, Ministerio
de Ciencia y Tecnologı´a) and complied with Royal Decree 1201/
2005 (Boletı´n Oficial del Estado, BOE no. 252) pertaining to the
protection of experimental animals and with the European
Communities Council Directive (86/609/EEC).
Thirty-six adult male Wistar rats (250610 g) were individually
caged with a 12-h light/dark cycle and fed standard chow and
water ad libitum. After an overnight fast, rats were anesthetized
(0.02 ml of ketamine/100 g wt and 0.04 ml of xylazine/100 g wt)
and positioned in a stereotaxic apparatus. A cannula attached to
an osmotic minipump (Alzet, Durect Corp., Cupertino, CA, USA)
containing either saline or leptin was implanted into the right
cerebral ventricle (20.3 mm anteroposterior, 1.1 mm lateral from
Bregma). Leptin was dissolved in saline plus 1% BSA and insulin
was dissolved in PBS. Rats were treated icv for 14 days with either
saline with 1% BSA or leptin (12 mg/day). To discriminate
between the direct effects of leptin from those due to induction of
decreased food intake, we included a pair-fed group that received
the same amount of food consumed by the leptin-treated group the
day before. Food intake and body weight were measured daily.
Rats were sacrificed by decapitation at 8.00 h after a 12 h fast,
inguinal fat as subcutaneous adipose tissue and epididymal fat as
visceral tissue were isolated and blood collected.
Determination of insulin sensitivity, insulin tolerance and
insulin resistance
On the last day of infusion, after a fasting period of 12 hours,
10 mIU of insulin or PBS in a volume of 5 ml were injected icv and
rats were sacrificed by decapitation 2 hours later. This resulted in
the following groups (n = 6 per group): chronic saline with 1%
BSA (control, C), chronic saline with 1% BSA plus caloric
restriction (pair-fed, PF), chronic leptin (leptin, L), chronic saline
with 1% BSA plus acute insulin (insulin, I), 5) chronic saline with
1% BSA plus acute insulin and caloric restriction (insulin + pair-
fed, PF+I) and 6) chronic leptin plus acute insulin (leptin + insulin,
L+I). Blood was incubated at room temperature for 30 min,
centrifuged at 1,500 g for 10 min at 4uC and serum collected and
frozen at 280uC until determination of leptin, insulin and
cytokines. Glycemia was measured before and 120 min after
insulin administration via tail puncture (Accu-Check Sensor,
Roche, Mannheim, Germany).
Insulin tolerance was assessed by performing an ip insulin
tolerance test (IPITT) after the injection of a bolus of insulin
(Regular Humuline, Lilly; 2 U/kg ip) and blood samples were
drawn consecutively at 0, 30, 60, 90 and 120 min for glucose
measurement [73], as described above.
In addition, homeostasis model assessment of insulin resistance
(HOMA-IR) index was calculated with the following formula:
HOMA-IR = [Glucose (mmol/l) 6 insulin (mU/ml)]/22.5.
Insulin sensitivity was measured as delta (D) in glycemia, calculated
as glycemia after 120 min of insulin bolus minus glycemia before
insulin bolus.
ELISAs
Serum leptin and insulin levels were measured with ELISA kits
according to the manufacturer’s instructions. The sensitivity of the
assays for leptin and insulin were 0.04 and 0.2 ng/ml, respectively.
The intra-assay variations were 2.2% for leptin and 1.9% for
insulin and the inter-assay variations were 3.4% for leptin and
7.6% for insulin. Haptoglobin concentrations in adipose fat depots
were determined by an ELISA kit from AssayPro (St. Charles,
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MO, USA). The intra- and inter-assay variations for haptoglobin
were 5.2% and 7.9%, respectively.
Tissue homogenization and protein quantification
Adipose tissues were homogenized on ice in 500 ml radioim-
munoprecipitation assay lysis buffer (RIPA; 50 mM NaH2PO4,
100 mM Na2HPO4, 0.1% sodium dodecyl sulfate, 0.5% NaCl,
1% Triton X-100) with EDTA-free protease inhibitors (Roche
Diagnostics, Barcelona, Spain), 1 mM phenylmethanesulfonyl-
fluoride and 5 mg/ml sodium deoxycholate for extraction of
cytokines and leptin and insulin signaling-related proteins. The
lysates were incubated overnight at 270uC and then centrifuged
at 12,000 g for 5 min at 4uC. The supernatant was stored at
280uC until assayed. Total protein concentration was determined
by the method of Bradford (Bio-Rad Laboratories).
Multiplexed bead immunoassay
Serum and tissue IL-2, -4, -6, -10, IFN-c and TNF-a
concentrations were measured by a multiplexed bead immunoas-
say. Briefly, after blockage of the filter plate with assay buffer, wells
were washed by using a vacuum manifold and beads with different
fluorescent labeling for each antigen conjugated to the appropriate
antibodies and serum (25 ml each) were added and then incubated
for 18 hours at 4uC. Wells were washed and 25 ml of antibody
conjugated to biotin were added. After incubation for 30 min at
room temperature, beads were incubated during 30 min with
50 ml streptavidin conjugated to phycoerythrin. After washing,
beads were resuspended and a minimum of 50 beads per
parameter was analyzed in the Bio-Plex suspension array system
200 (Bio-Rad Laboratories, Madrid, Spain). Raw data (mean
fluorescence intensity, MFI) was analyzed by using the Bio-Plex
Manager Software 4.1 (Bio-Rad Laboratories). Sensitivity is
approximately 2–5 pg/ml, mean intra-assay variation was 8.0%
and mean inter-assay variation was 12.6% for all cytokines.
Western blotting
Western blotting was used to determine levels of SOCS3 and
insulin receptor and activation of STAT3 and Akt in subcutaneous
and visceral adipose tissues. The proteins were resolved on a 10%
SDS-polyacrylamide gel and then transferred to polyvinyl
difluoride (PVDF) membranes. Membranes were blocked with
TTBS containing 5% (w/v) BSA during 2 h at 25uC and
incubated with the corresponding primary antibody (diluted
1:1000) in TTBS at 4uC overnight. The membranes were
subsequently washed and incubated with the corresponding
secondary antibody conjugated with peroxidase at a dilution of
1:2000 in TTBS during 90 min at 25uC. The proteins were
detected by chemiluminescence with an ECL system. Quantifica-
tion of the bands obtained was carried out by densitometry using a
Kodak Gel Logic 1500 Image Analysis system and Molecular
Imaging Software version 4.0 (Rochester, NY, USA). Insulin
receptor, FOXO1, PTP1B, SOCS3 and vimentin were normal-
ized with actin and pAkt and pSer727STAT3 with their total
forms.
RNA purification and real time PCR analysis
Total RNA was extracted according to the Qiazol protocol
(Qiagen Sciences, Maryland, USA). Reverse transcription was
performed on 2 mg of total RNA using the high-capacity cDNA
archive kit (Applied Biosystems). Real-time PCR was performed in
an ABI Prism 7000 Sequence Detection System (Applied
Biosystems) using TaqMan PCR Master Mix (Applied Biosystems)
and the thermocycler parameters recommended by the manufac-
turer. PCRs were performed in duplicate in a total volume of
50 ml, containing 25 ml of the reverse transcription reaction.
TaqMan gene expression assays were used for IL-2, IL-4, IFN-c,
leptin, ObR and TNF-a (Rn00587673_m1, Rn01456866_m1,
Rn00594078_m1, Rn00565158_m1, Rn01433205_m1 and
Rn01525859_g1, respectively; Applied Biosystems). All expression
assays were performed following the manufacturer’s procedures,
except ObR, that was done following the modifications of Siegrist-
Kaiser et al. [74]. Relative gene expression comparisons were
carried-out using an invariant endogenous control (actin).
According to manufacturer’s guidelines, the DDCT method was
used for relative quantification.
Statistical analysis
Differences between groups were analyzed by a one-way
ANOVA followed by a Bonferronis test. Statistical significance
was set at p,0.05. Pearson’s correlation coefficient r was used to
measure the degree of association between different variables in
each group. Two-tailed p values ,0.05 were considered signifi-
cant. These correlations were conducted with Prism software 4.00
(GraphPad, San Diego, CA, USA). The trapezoidal rule of
GraphPad Prism was employed to calculate the area under the
curve. Data are expressed as mean 6 SEM.
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